Anti-human HER3 antibodies and uses thereof
US9127065B2 · kind B2 · utility
3Cited by
0References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 21, 2012 |
| Grant date | Sep 8, 2015 |
| Priority date | — |
| Expiry date | May 21, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides for isolated anti-human-HER3 antibodies or fragments thereof. More particularly the present invention provides an isolated monoclonal antibody that specifically binds to the extracellular domain of HER-3 and competes for binding to the extracellular domain of human HER-3 with the antibody produced obtainable from hybridoma deposited as CNCM-I-4486. The antibodies described in the present invention are useful for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.